Dopamine transporter genotype influences the physiological response to medication in ADHD

By Gilbert Donald L.   Wang Zhewu   Sallee Floyd R.   Ridel Keith R.   Merhar Stephanie   Zhang Jie   Lipps Tara D.   White Colin   Badreldin Nevert   Wassermann Eric M.  

Brain, Vol. 129, Iss. 8, 2006-08 ,pp. : 2038-2046

Oxford University Press

Access to resources Recommend Favorite

Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson’s disease

By Happe S.   Tings T.   Koch W.   Welsch J.   Helmschmied K.   Baier P. C.   Meller J.   Wuttke W.   Paulus W.   Tatsch K.   Trenkwalder C.  

Journal of Neural Transmission, Vol. 114, Iss. 5, 2007-05 ,pp. : 589-594

Springer Publishing Company

Access to resources Recommend Favorite

Trafficking of adenosine A_2A and dopamine D₂ receptors

By Torvinen Maria   Torri Carla   Tombesi Andrea   Marcellino Daniel   Watson Stan   Lluis Carmen   Franco Rafael   Fuxe Kjell   Agnati Luigi  

Journal of Molecular Neuroscience, Vol. 25, Iss. 2, 2005-06 ,pp. : 191-200

Humana Press, Inc

Access to resources Recommend Favorite

Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration

By Storch A.   Ludolph A. C.   Schwarz J.  

Journal of Neural Transmission, Vol. 111, Iss. 10-11, 2004-10 ,pp. : 1267-1286

Springer Publishing Company

Access to resources Recommend Favorite

Central and peripheral dopamine transporter reduction in Parkinson's disease

By Buttarelli Francesca R.   Capriotti Gabriela   Pellicano Clelia   Prosperi Daniela   Circella Annapia   Festa Anna   Giovannelli Morena   Tofani Anna   Pontieri Francesco E.   Scopinaro Francesco  

Neurological Research, Vol. 31, Iss. 7, 2009-09 ,pp. : 687-691

Maney Publishing

Access to resources Recommend Favorite